Jasper Therapeutics Statistics

Total Valuation

JSPR has a market cap or net worth of $9.55 million. The enterprise value is -$3.84 million.

Market Cap	9.55M
Enterprise Value	-3.84M

Important Dates

The next estimated earnings date is Wednesday, August 12, 2026, after market close.

Earnings Date	Aug 12, 2026
Ex-Dividend Date	n/a

Share Statistics

JSPR has 28.00 million shares outstanding. The number of shares has increased by 50.47% in one year.

Current Share Class	28.00M
Shares Outstanding	28.00M
Shares Change (YoY)	+50.47%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	1.19%
Owned by Institutions (%)	41.47%
Float	21.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.81
P/TBV Ratio	2.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.22.

Current Ratio	2.26
Quick Ratio	1.57
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -244.21% and return on invested capital (ROIC) is -180.47%.

Return on Equity (ROE)	-244.21%
Return on Assets (ROA)	-112.23%
Return on Invested Capital (ROIC)	-180.47%
Return on Capital Employed (ROCE)	-580.35%
Weighted Average Cost of Capital (WACC)	19.25%
Revenue Per Employee	n/a
Profits Per Employee	-$2.53M
Employee Count	22
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -93.87% in the last 52 weeks. The beta is 3.00, so JSPR's price volatility has been higher than the market average.

Beta (5Y)	3.00
52-Week Price Change	-93.87%
50-Day Moving Average	0.75
200-Day Moving Average	1.48
Relative Strength Index (RSI)	24.67
Average Volume (20 Days)	800,308

Short Selling Information

The latest short interest is 2.25 million, so 8.03% of the outstanding shares have been sold short.

Short Interest	2.25M
Short Previous Month	2.49M
Short % of Shares Out	8.03%
Short % of Float	10.23%
Short Ratio (days to cover)	9.69

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-70.73M
Pretax Income	-55.73M
Net Income	-55.73M
EBITDA	-69.94M
EBIT	-70.73M
Earnings Per Share (EPS)	-$2.47

Full Income Statement

Balance Sheet

The company has $14.14 million in cash and $757,000 in debt, giving a net cash position of $13.39 million or $0.48 per share.

Cash & Cash Equivalents	14.14M
Total Debt	757,000
Net Cash	13.39M
Net Cash Per Share	$0.48
Equity (Book Value)	3.40M
Book Value Per Share	0.12
Working Capital	11.30M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$68.87 million and capital expenditures -$7,000, giving a free cash flow of -$68.87 million.

Operating Cash Flow	-68.87M
Capital Expenditures	-7,000
Depreciation & Amortization	798,000
Net Borrowing	n/a
Free Cash Flow	-68.87M
FCF Per Share	-$2.46

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

JSPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-50.47%
Shareholder Yield	-50.47%
Earnings Yield	-583.79%
FCF Yield	-721.43%

Analyst Forecast

The average price target for JSPR is $8.63, which is 2,430.79% higher than the current price. The consensus rating is "Buy".

Price Target	$8.63
Price Target Difference	2,430.79%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 4, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date	Jan 4, 2024
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a